Corporate Profile

La Jolla Pharmaceutical Company is a publicly traded biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases.
Featured Documents
More information is coming soon.

Share Price

Price
Change (%)  (%)
Volume
Data as of

Copyright West LLC. Minimum 15 minutes delayed.

Upcoming Events
There are currently no events scheduled.
Recent News
La Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical Results
11/25/19
SAN DIEGO , Nov. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that it
Read More →
La Jolla Pharmaceutical Company Announces Management Transition
11/25/19
SAN DIEGO , Nov. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced that
Read More →
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Progress
11/12/19
SAN DIEGO , Nov. 12, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company  (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today announced
Read More →